SARS-CoV-2-IN-110
Product Specifications
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
SARS-CoV-2-IN-110 (compound Bb1) is an inhibitor of SARS-CoV-2, demonstrating antiviral efficacy with an EC50 of 1.10 μM, and significantly reduced toxicity compared to Lapatinib. The compound exhibits a CC50 of greater than 100 μM against SARS-CoV-2, with a selectivity index (SI) exceeding 91.
Molecular Formula
C28H20ClFN4O2
Molecular Weight
498.94
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9422547-01 0.02 mg
Recombinant Human Vascular endothelial growth factor B
Sign In for Pricing
View Details MBS9422547-02 0.1 mg
Recombinant Human Vascular endothelial growth factor B
Sign In for Pricing
View Details MBS9422547-03 1 mg
Recombinant Human Vascular endothelial growth factor B
Sign In for Pricing
View Details MBS9422547-04 5x 1 mg
Recombinant Human Vascular endothelial growth factor B
Sign In for Pricing
View Details